Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc.

ELDN
Eledon Pharmaceuticals, Inc.US flagNASDAQ Capital Market
3.95
USD
+0.09
- -
236.80MMarket Cap

Eledon Pharmaceuticals, Inc. (ELDN) Stock Split History

Learn about Eledon Pharmaceuticals, Inc.'s most recent 1-for-18 basis stock split on October 05, 2020. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Eledon Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2020-10-05
Split Ratio: 1:18
Price Before Split: $1.02
Price After Split: $0.06

Developer API

Get ELDN split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ELDN

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 18.00 times fewer shares (a 1:18 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Eledon Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2020-10-051:18Yes$1.02$0.06
2017-05-111:9Yes$0.71$0.08

About Eledon Pharmaceuticals, Inc.

Company overview and industry information

Eledon Pharmaceuticals, Inc. (ELDN) operates in the Biotechnology industry. The recent 1-for-18 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Eledon Pharmaceuticals, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.